AP
Arrowhead Pharmaceuticals Inc
🇩🇪XSTU.HDP1GermanyHealthcare
€57.16EURdown -13.00 (-18.53%)OpenEnd of day9:16 AM
Price€57.16-13.00 (-18.53%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US04280A1007
- CUSIP
- Not reported
Company
- Employees
- 711
- Headquarters
- Pasadena, United States
- Website
- https://arrowheadpharma.com
- CEO
- Dr. Christopher R. Anzalone Ph.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Key dates
- Next earnings
- Nov 24, 2026
Highlights
- Market cap
- Not reported
- EPS LTM
- -$2.23
- P/E LTM
- -36.43
- Div yield
- 0.69%
Fundamentals (LTM)
- Revenue
- $669.5M+12.22%up year on year
- Net income
- -$319.95M-115.58%down year on year
- Gross margin
- 97.14%+0.96%up year on year
- Free cash flow
- -$75.11M-326.26%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.